When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OMER - Omeros' OMS721 shows positive effect in mid-stage IgA nephropathy study in steroid -free patients
Omeros Corporation
Omeros (OMER-5.3%) announces positive results from a Phase 2 clinical trial evaluating OMS721 in corticosteroid therapy-naive patients with immunoglobulin A (IgA) nephropathy.
More news on: Omeros Corporation, Healthcare stocks news, Stocks on the move,